NVP Associates
Latest statistics and disclosures from NVP Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are OMDA, ZBIO, MBX, TALK, GROV, and represent 100.00% of NVP Associates's stock portfolio.
- Reduced shares in these 2 stocks: DAVE (-$63M), OPEN.
- Sold out of its positions in DAVE, OPEN.
- NVP Associates was a net seller of stock by $-65M.
- NVP Associates has $166M in assets under management (AUM), dropping by -9.83%.
- Central Index Key (CIK): 0001545692
Tip: Access up to 7 years of quarterly data
Positions held by NVP Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for NVP Associates
NVP Associates holds 5 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Omada Health (OMDA) | 33.7 | $56M | 2.5M | 22.11 |
|
|
| Zenas Biopharma (ZBIO) | 24.6 | $41M | 1.8M | 22.20 |
|
|
| Mbx Biosciences (MBX) | 22.5 | $37M | 2.1M | 17.50 |
|
|
| Talkspace (TALK) | 16.3 | $27M | 9.8M | 2.76 |
|
|
| Grove Collaborative Hold Com Cl A (GROV) | 2.9 | $4.8M | 3.2M | 1.50 |
|
Past Filings by NVP Associates
SEC 13F filings are viewable for NVP Associates going back to 2022
- NVP Associates 2025 Q3 filed Nov. 14, 2025
- NVP Associates 2025 Q2 filed Aug. 14, 2025
- NVP Associates 2025 Q1 filed May 12, 2025
- NVP Associates 2024 Q4 filed Feb. 10, 2025
- NVP Associates 2024 Q3 filed Nov. 12, 2024
- NVP Associates 2024 Q2 filed Aug. 13, 2024
- NVP Associates 2024 Q1 filed May 10, 2024
- NVP Associates 2023 Q4 filed Feb. 14, 2024
- NVP Associates 2023 Q3 filed Nov. 8, 2023
- NVP Associates 2023 Q2 filed Aug. 1, 2023
- NVP Associates 2023 Q1 filed May 15, 2023
- NVP Associates 2022 Q4 filed Feb. 14, 2023